Action Seer - SEER

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Dernier

2,31

Prix Achat

2,17

Prix Vente

9,14

Volume échangé

218 671

2,28 Fourchette du Jour 2,365

1,51 Plage de 52 semaines 2,625

Cap du marché

136,213M

Clôture Veille

2,32

Ouverture

2,31

Dernière Transaction

2.36

Dernière heure de transaction

Volume financier

US$ 507 946

VWAP

2,3229

Volume moyen (3 m)

246 028

Actions en circulation

58 966 560

Rendement du Dividende

Ratio Cours sur Bénéfices

-1,57

Bénéfice par action (BPA)

-1,46

Chiffre d'affairess

16,66M

Bénéfice net

-86,28M

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased... Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Show more

Secteur

Lab Analytical Instruments

Industrie

Lab Analytical Instruments

Site Web

www.seer.bio

Siège social

Wilmington, Delaware, USA

Fondé

Seer Inc est coté dans le secteur Lab Analytical Instruments de la NASDAQ avec le ticker SEER. Le dernier cours de clôture d'Seer était de US$2,32. Au cours de la dernière année, les actions de Seer ont été négociées dans une fourchette de prix de US$ 1,51 à US$ 2,625.

Seer compte actuellement 58 966 560 actions en circulation. La capitalisation boursière d'Seer est de US$136,80 million. Seer a un ratio cours/bénéfice (ratio PE) de -1.57.

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

REDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it...

Seer to Participate in Upcoming November Investor Conferences

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Seer Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported...

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a...

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the...

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements...

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

REDWOOD CITY, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

Form 4 - Statement of changes in beneficial ownership of securities

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.135	-5.52147239264	2.445	2.52	2.2025	193138	2.36136884	CS
4	-0.07	-2.94117647059	2.38	2.625	2.2025	210049	2.4478365	CS
12	0.46	24.8648648649	1.85	2.625	1.82	246028	2.19344742	CS
26	0.64	38.3233532934	1.67	2.625	1.56	387932	1.87518661	CS
52	0.49	26.9230769231	1.82	2.625	1.51	425101	1.86074291	CS
156	-20.09	-89.6875	22.4	24.66	1.455	385999	5.33342826	CS
260	-45.69	-95.1875	48	86.55	1.455	413983	16.59906795	CS

SEER - Frequently Asked Questions (FAQ)

What is the current Seer share price?

The current share price of Seer is US$ 2,31

How many Seer shares are in issue?

Seer has 58 966 560 shares in issue

What is the market cap of Seer?

The market capitalisation of Seer is USD 136,8M

What is the 1 year trading range for Seer share price?

Seer has traded in the range of US$ 1,51 to US$ 2,625 during the past year

What is the PE ratio of Seer?

The price to earnings ratio of Seer is -1,57

What is the cash to sales ratio of Seer?

The cash to sales ratio of Seer is 8,14

What is the reporting currency for Seer?

Seer reports financial results in USD

What is the latest annual turnover for Seer?

The latest annual turnover of Seer is USD 16,66M

What is the latest annual profit for Seer?

The latest annual profit of Seer is USD -86,28M

What is the registered address of Seer?

The registered address for Seer is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Seer website address?

The website address for Seer is www.seer.bio

Which industry sector does Seer operate in?

Seer operates in the LAB ANALYTICAL INSTRUMENTS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
MYSZMy Size Inc	US$ 4,2001 (211,12%)	121,03M
NVNINVNI Group Ltd	US$ 8,26 (209,36%)	78,06M
TPICTPI Composites Inc	US$ 2,45 (100,82%)	34M
ICGIntchains Group Ltd	US$ 8,77 (88,60%)	527,94k
HSDTHelius Medical Technologies Inc	US$ 0,884851 (84,34%)	121,95M
CYNCYNGN Inc	US$ 0,4603 (-71,41%)	27,91M
MTEMMolecular Templates Inc	US$ 0,1502 (-57,09%)	8,75M
PRFXPainReform Ltd	US$ 5,15 (-53,85%)	2,94M
GALTGalectin Therapeutics Inc	US$ 1,03 (-48,50%)	9,27M
BCABBioAtla Inc	US$ 0,6923 (-41,82%)	6,25M
EDBLEdible Garden AG Inc	US$ 0,24 (65,06%)	354,33M
NVDANVIDIA Corporation	US$ 134,70 (3,08%)	310,19M
APTOAptose Biosciences Inc	US$ 0,28 (64,51%)	306,25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0,606999 (6,49%)	293,22M
PLTRPalantir Technologies Inc	US$ 80,55 (8,54%)	281,23M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Seer Inc (SEER) Cours

Seer Inc (SEER)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

À propos de Seer Inc

SEER Dernières nouvelles

SEER - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application